Xenon Pharmaceuticals (XENE) Net Cash Flow: 2013-2025
Historic Net Cash Flow for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to -$30.9 million.
- Xenon Pharmaceuticals' Net Cash Flow rose 37.23% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year increase of 249.67%. This contributed to the annual value of -$4.3 million for FY2024, which is 104.68% down from last year.
- As of Q3 2025, Xenon Pharmaceuticals' Net Cash Flow stood at -$30.9 million, which was down 270.58% from $18.1 million recorded in Q2 2025.
- Over the past 5 years, Xenon Pharmaceuticals' Net Cash Flow peaked at $254.3 million during Q2 2022, and registered a low of -$263.8 million during Q3 2022.
- Moreover, its 3-year median value for Net Cash Flow was $5.8 million (2023), whereas its average is $1.7 million.
- Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Net Cash Flow was 5,427.59% (2022), while the steepest drop was 5,053.06% (2022).
- Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Net Cash Flow stood at $87.8 million in 2021, then plummeted by 153.59% to -$47.1 million in 2022, then surged by 203.74% to $48.8 million in 2023, then increased by 15.21% to $56.2 million in 2024, then skyrocketed by 37.23% to -$30.9 million in 2025.
- Its last three reported values are -$30.9 million in Q3 2025, $18.1 million for Q2 2025, and -$26.0 million during Q1 2025.